Cell Source, Inc. (CLCS)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-09-01 | Phase1 Readout | — |
| 2026-11-01 | Phase2 Readout | — |
| 2026-12-01 | Phase2 Readout | — |
| 2027-05-31 | Phase3 Readout | — |
| 2027-06-01 | Phase2 Readout | — |
Active Clinical Trials (25)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07651787 | Using Light Therapy for Mild Cognitive Impairment | OTHER | Recruiting | 40 |
| NCT03844828 | Clinical Study to Investigate Outcomes of Trifocal Toric IOL POD FT in Asian Eyes | OTHER | Active Not Recruiting | 100 |
| NCT06869486 | Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors | OTHER | Recruiting | 300 |
| NCT07269847 | Comparing a Healthy Beef-Centric Diet to a Healthy U.S.-Style Diet on Metabolic Health Outcomes in Pre-Diabetic Adults | OTHER | Recruiting | 56 |
| NCT05009758 | Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With... | OTHER | Recruiting | 30 |
| NCT06623357 | Pilot Test of Caregiver Training Protocol for Brachial Plexus Birth Injury | OTHER | Recruiting | 20 |
| NCT04314401 | National Cancer Institute "Cancer Moonshot Biobank" | OTHER | Active Not Recruiting | 1,600 |
| NCT05417971 | Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation | OTHER | Recruiting | 20 |
| NCT07355491 | Performance Evaluation of Dream OCT: AP Study | OTHER | Recruiting | 120 |
| NCT03616041 | Capsule Endoscopy for Severe Hematochezia | OTHER | Recruiting | 23 |
| NCT07209683 | The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults | OTHER | Recruiting | 30 |
| NCT06384924 | Raman Spectroscopy and Skin Cancer | OTHER | Recruiting | 20 |
| NCT06935357 | A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) | PHASE3 | Recruiting | 454 |
| NCT06158841 | Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Particip... | PHASE3 | Recruiting | 380 |
| NCT07254806 | A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to... | PHASE3 | Recruiting | 162 |
| NCT07339111 | Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis | PHASE3 | Recruiting | 300 |
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | PHASE3 | Active Not Recruiting | 729 |
| NCT06428019 | A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combinatio... | PHASE3 | Recruiting | 170 |
| NCT06865105 | Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis | PHASE2 | Recruiting | 120 |
| NCT07221565 | Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT) | PHASE2 | Enrolling By Invitation | 120 |
| NCT03913026 | UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia | PHASE2 | Active Not Recruiting | 30 |
| NCT02600208 | Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using... | PHASE2 | Active Not Recruiting | 60 |
| NCT05739643 | Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT | PHASE2 | Active Not Recruiting | 9 |
| NCT05421325 | Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infecti... | PHASE2 | Recruiting | 72 |
| NCT03911388 | HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors | PHASE1 | Recruiting | 24 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.